Hemex Health is a medical diagnostic device company specializing in affordable and life-changing diagnostics for malaria and sickle cell disease. The company operates in the healthcare sector, focusing on underserved populations globally. Hemex Health's core product is the Gazelle Platform, a novel diagnostic tool designed to be accessible and effective in low-resource settings. The company serves healthcare providers, NGOs, and government health programs that aim to improve health outcomes in regions with high incidences of these diseases.

Hemex Health's business model revolves around the development and distribution of its diagnostic devices. The company generates revenue through the sale of its diagnostic platforms and related consumables. Additionally, Hemex Health secures funding through grants and investments, such as the SBIR Matching Grant from Business Oregon and investment from TiE Global Angels.

The company has been recognized for its innovative solutions, winning several awards and grants, including the Vodafone Foundation Wireless Innovation Contest and the USPTO Patents for Humanity Award. Hemex Health collaborates with various partners, including Case Western Reserve University and Tata Elxsi, to enhance its product offerings and expand its market reach.

Keywords: medical diagnostics, malaria, sickle cell disease, underserved populations, Gazelle Platform, healthcare innovation, low-resource settings, diagnostic devices, healthcare providers, global health.